Abstract
Caenorhabditis elegans (C. elegans) allows exhaustive analysis of animal biology, in detail once thought possible only for microbial organisms. This detail includes the entire cellular lineage from egg to adult, the complete adult cell complement, a full wiring diagram of the nervous system, and several hundred gene mutants that produce classical phenotypes. With the rise of genomic sequencing and functional genomics, analysis of C. elegans has grown to include reverse genetics, microarray assays of gene expression, and protein-protein interactions. Such studies should soon touch upon all ∼19,400 predicted C. elegans proteins and their detailed expression patterns. This should illuminate, but also complicate, our understanding of C. elegans cells and genetic pathways. Moreover, the newer forms of analysis are explicitly directed at acquiring data that are highly valuable with computational analysis but unintelligible without it. We describe the existing data sets and databases for C. elegans, and discuss ways in which large C. elegans data sets may be integrated.
Keywords: Caenorhabditis elegans, genomics
Current Genomics
Title: Caenorhabditis elegans Databases
Volume: 3 Issue: 2
Author(s): E. M. Schwarz, L. D. Stein and P. W. Sternberg
Affiliation:
Keywords: Caenorhabditis elegans, genomics
Abstract: Caenorhabditis elegans (C. elegans) allows exhaustive analysis of animal biology, in detail once thought possible only for microbial organisms. This detail includes the entire cellular lineage from egg to adult, the complete adult cell complement, a full wiring diagram of the nervous system, and several hundred gene mutants that produce classical phenotypes. With the rise of genomic sequencing and functional genomics, analysis of C. elegans has grown to include reverse genetics, microarray assays of gene expression, and protein-protein interactions. Such studies should soon touch upon all ∼19,400 predicted C. elegans proteins and their detailed expression patterns. This should illuminate, but also complicate, our understanding of C. elegans cells and genetic pathways. Moreover, the newer forms of analysis are explicitly directed at acquiring data that are highly valuable with computational analysis but unintelligible without it. We describe the existing data sets and databases for C. elegans, and discuss ways in which large C. elegans data sets may be integrated.
Export Options
About this article
Cite this article as:
Schwarz M. E., Stein D. L. and Sternberg W. P., Caenorhabditis elegans Databases, Current Genomics 2002; 3(2) . https://dx.doi.org/10.2174/1389202024605189
DOI https://dx.doi.org/10.2174/1389202024605189 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNAzymes: From Creation In Vitro to Application In Vivo
Current Pharmaceutical Biotechnology Multilanthanide Systems for Medical Imaging Applications
Recent Patents on Nanomedicine Quality of Life of Children with Cerebral Palsy: A Cross-Sectional KIDSCREEN study in the Southern part of the Netherlands
CNS & Neurological Disorders - Drug Targets Mixed Lineage Kinase Family, Potential Targets for Preventing Neurodegeneration
Current Medicinal Chemistry - Central Nervous System Agents Protein Kinase Substrate Profiling with a High-Density Peptide Microarray
Combinatorial Chemistry & High Throughput Screening NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Anti-Cancer Agents in Medicinal Chemistry Lectin Techniques for Glycoproteomics
Current Proteomics Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition
Anti-Cancer Agents in Medicinal Chemistry Glycosite Analysis in Glycoproteomics by Mass Spectrometry
Current Proteomics Chemical Constituents and Biological Activity of Chinese Medicinal Herb ‘Xihuangcao’
Combinatorial Chemistry & High Throughput Screening Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate
Current Neuropharmacology Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry Cadmium as an Endocrine Disruptor in the Reproductive System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Distribution of Chloroaluminum Phthalocyanine in a Lipid Nano-Emulsion as Studied by Second-Derivative Spectrophotometry
Micro and Nanosystems Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Antioxidant Components of Brassica Vegetables Including Turnip and the Influence of Processing and Storage on their Anti-oxidative Properties
Current Medicinal Chemistry Chemical Structure and Surface Modification of Dendritic Nanomaterials Tailored for Therapeutic and Diagnostic Applications
Current Topics in Medicinal Chemistry Development and Validation of a High-Density Fluorescence Polarization-Based Assay for the Trypanosoma RNA Triphosphatase TbCet1
Combinatorial Chemistry & High Throughput Screening Glycomics: Towards Bioinformatic Approaches to Understanding Glycosylation
Anti-Cancer Agents in Medicinal Chemistry